PMID- 23580786 OWN - NLM STAT- MEDLINE DCOM- 20140217 LR - 20211021 IS - 1554-6179 (Electronic) IS - 1539-4182 (Print) IS - 1539-4182 (Linking) VI - 11 IP - 2 DP - 2013 Jun TI - Circadian patterns of ST elevation myocardial infarction in the new millennium. PG - 66-72 LID - 10.3121/cmr.2013.1120 [doi] AB - OBJECTIVE: Nearly four decades ago, a circadian pattern of acute myocardial infarction (AMI) with a peak in the early morning waking hours was described. The goal of the present study was to determine whether major changes in lifestyle and significant advances in medical therapy have altered this pattern in the intervening years. DESIGN: Retrospective chart review. SETTING: Tertiary care hospital in central Wisconsin. METHODS: We examined circadian patterns of ST elevation myocardial infarction (STEMI) in 519 patients diagnosed with STEMI over a 5-year period. Time of symptom onset was obtained from patient self-reports in the medical record and was recorded over 24 hours. RESULTS: We observed a circadian pattern of STEMI occurrence with a morning peak at approximately 11:30 AM. This pattern was highly significant in patients who were not using beta-blockers (P <0.0001) and had no history of diabetes (P <0.0001), but was otherwise absent. The circadian pattern appeared to be attenuated in patients of a younger age, female gender, or who used statins or aspirin. Peak STEMI occurrence was earlier in smokers than non-smokers. CONCLUSIONS: Despite significant lifestyle changes and medical advances in the nearly four decades since a circadian pattern of AMI occurrence was first described, patients with STEMI had a circadian pattern of symptom onset with a morning peak. Use of beta-blockers and a history of diabetes mellitus abolished this pattern. Other modifying factors, including medications, age, and gender attenuated, but did not abolish, the circadian pattern. FAU - Kanth, Rajan AU - Kanth R AD - Department of Internal Medicine, Marshfield Clinic, Marshfield, WI 54449, USA. FAU - Ittaman, Sunitha AU - Ittaman S FAU - Rezkalla, Shereif AU - Rezkalla S LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130411 PL - United States TA - Clin Med Res JT - Clinical medicine & research JID - 101175887 RN - 0 (Adrenergic beta-Antagonists) RN - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) RN - R16CO5Y76E (Aspirin) SB - IM MH - Adrenergic beta-Antagonists/therapeutic use MH - Adult MH - Age Factors MH - Aged MH - Aged, 80 and over MH - Aspirin/therapeutic use MH - Cardiology/*trends MH - Circadian Rhythm/*physiology MH - *Electrocardiography MH - Female MH - Humans MH - Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use MH - Life Style MH - Male MH - Middle Aged MH - Myocardial Infarction/*drug therapy/*physiopathology MH - Retrospective Studies MH - Sex Factors MH - Tertiary Care Centers MH - Wisconsin PMC - PMC3692391 OTO - NOTNLM OT - Beta-blockers OT - Circadian rhythm OT - Diabetes OT - Myocardial infarction EDAT- 2013/04/13 06:00 MHDA- 2014/02/18 06:00 PMCR- 2013/06/01 CRDT- 2013/04/13 06:00 PHST- 2013/04/13 06:00 [entrez] PHST- 2013/04/13 06:00 [pubmed] PHST- 2014/02/18 06:00 [medline] PHST- 2013/06/01 00:00 [pmc-release] AID - cmr.2013.1120 [pii] AID - 0110066 [pii] AID - 10.3121/cmr.2013.1120 [doi] PST - ppublish SO - Clin Med Res. 2013 Jun;11(2):66-72. doi: 10.3121/cmr.2013.1120. Epub 2013 Apr 11.